Home | News | Directories | Calendar | Maps | Contact Us | Webmail
Perelman School of Medicine at the University of Pennsylvania Advanced Search

Roger B Cohen,

Roger B Cohen

faculty photo
Professor of Medicine at the Hospital of the University of Pennsylvania
Department: Medicine

Contact information
Division of Hematology-Oncology
Department of Medicine
University of Pennsylvania School of Medicine
Philadelphia, PA 19104
Office: 2156624469
Education:
A.B. (Biochemical Sciences)
Harvard College (magna cum laude), 1976.
M.D. (Medicine)
Harvard Medical School, 1980.
Permanent link
 
Perelman School of Medicine > Faculty > Search

Selected Publications

Chiorean EG, Hurwitz HI, Cohen RB, Schwartz JD, Dalal RP, Fox FE, Gao L, Sweeney CJ.: Phase I study of every 2- or 3-week dosing of ramucirumab, a human immunoglobulin G1 monoclonal antibody targeting the vascular endothelial growth factor receptor-2 in patients with advanced solid tumors. Ann Oncol 26(6): 1230-7, March 2015

Rixe Olivier, Puzanov Igor, LoRusso Patricia M, Cohen Roger B, Morris John C, Olowokure Olugbenga O, Yin Jian Y, Doroumian Séverine, Shen Liji, Olszanski Anthony J: Phase I dose-escalation study of cabazitaxel administered in combination with gemcitabine in patients with metastatic or unresectable advanced solid malignancies. Anti-cancer drugs 26(7): 785-92, Aug 2015.

Grover Surbhi, Swisher-McClure Samuel, Mitra Nandita, Li Jiaqi, Cohen Roger B, Ahn Peter H, Lukens John N, Chalian Ara A, Weinstein Gregory S, O'Malley Bert W, Lin Alexander: Total Laryngectomy Versus Larynx Preservation for T4a Larynx Cancer: Patterns of Care and Survival Outcomes. International journal of radiation oncology, biology, physics 92(3): 594-601, Jul 2015.

von Mehren Margaret, Bookman Michael, Meropol Neal J, Weiner Louis M, Sherman Eric, Li Jinhui, Knoblauch Roland, Parekh Trilok, Cohen Roger B: Phase I study of the safety and pharmacokinetics of trabectedin with docetaxel in patients with advanced malignancies. Cancer chemotherapy and pharmacology 75(5): 1047-55, May 2015.

Chiorean E G, Hurwitz H I, Cohen R B, Schwartz J D, Dalal R P, Fox F E, Gao L, Sweeney C J: Phase I study of every 2- or 3-week dosing of ramucirumab, a human immunoglobulin G1 monoclonal antibody targeting the vascular endothelial growth factor receptor-2 in patients with advanced solid tumors. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 26(6): 1230-7, Mar 2015.

Jimeno A, Shirai K, Choi M, Laskin J, Kochenderfer M, Spira A, Cline-Burkhardt V, Winquist E, Hausman D, Walker L, Cohen R B: A randomized, phase II trial of cetuximab with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic head and neck squamous cell cancer. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 26(3): 556-61, Mar 2015.

Kaczmar John M, Tan Kay See, Heitjan Daniel F, Lin Alexander, Ahn Peter H, Newman Jason G, Rassekh Christopher H, Chalian Ara A, O'Malley Bert W, Cohen Roger B, Weinstein Gregory S: HPV-related oropharyngeal cancer: risk factors for treatment failure in patients managed with primary surgery (TORS). Head & neck Sep 2014.

Mateo J, Berlin J, de Bono J S, Cohen R B, Keedy V, Mugundu G, Zhang Lianglin, Abbattista A, Davis C, Gallo Stampino C, Borghaei H: A first-in-human study of the anti-α5β1 integrin monoclonal antibody PF-04605412 administered intravenously to patients with advanced solid tumors. Cancer chemotherapy and pharmacology 74(5): 1039-46, Sep 2014.

Infante Jeffrey R, Dees E Claire, Olszanski Anthony J, Dhuria Shyeilla V, Sen Suman, Cameron Scott, Cohen Roger B: Phase I Dose-Escalation Study of LCL161, an Oral Inhibitor of Apoptosis Proteins Inhibitor, in Patients With Advanced Solid Tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 32(28): 3103-10, Aug 2014.

Lukens J Nicholas, Lin Alexander, Gamerman Victoria, Mitra Nandita, Grover Surbhi, McMenamin Erin M, Weinstein Gregory S, O'Malley Bert W, Cohen Roger B, Orisamolu Abimbola, Ahn Peter H, Quon Harry: Late consequential surgical bed soft tissue necrosis in advanced oropharyngeal squamous cell carcinomas treated with transoral robotic surgery and postoperative radiation therapy. International journal of radiation oncology, biology, physics 89(5): 981-8, Aug 2014.

back to top
Last updated: 09/01/2015
The Trustees of the University of Pennsylvania